Valeant Makes Skin Care Licensing Deal Amid Allergan Offer

Six Am Law 100 firms are advising as Valeant sells the licensing rights to several skin care products to Nestle for $1.4 billion as it ups its unsolicited bid for Botox maker Allergan.

Sign up for a free trial now!'s Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on
  • The free InPractice digital newsletter
  • Personalized legal news on the mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Newswire digital newsletter.